CervoMed (CRVO) Cash & Equivalents (2022 - 2025)
Historic Cash & Equivalents for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $9.4 million.
- CervoMed's Cash & Equivalents fell 6846.05% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 6846.05%. This contributed to the annual value of $9.0 million for FY2024, which is 1548.41% up from last year.
- CervoMed's Cash & Equivalents amounted to $9.4 million in Q3 2025, which was down 6846.05% from $8.3 million recorded in Q2 2025.
- In the past 5 years, CervoMed's Cash & Equivalents ranged from a high of $29.9 million in Q3 2024 and a low of $4.1 million during Q4 2022
- For the 4-year period, CervoMed's Cash & Equivalents averaged around $10.5 million, with its median value being $9.4 million (2025).
- Per our database at Business Quant, CervoMed's Cash & Equivalents skyrocketed by 18703.55% in 2024 and then plummeted by 6846.05% in 2025.
- CervoMed's Cash & Equivalents (Quarter) stood at $4.1 million in 2022, then soared by 90.37% to $7.8 million in 2023, then increased by 15.48% to $9.0 million in 2024, then rose by 4.87% to $9.4 million in 2025.
- Its Cash & Equivalents stands at $9.4 million for Q3 2025, versus $8.3 million for Q2 2025 and $10.5 million for Q1 2025.